J. Goldman & Co’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-970,584
| Closed | -$4.08M | – | 421 |
|
|
2023
Q1 | $4.08M | Buy |
970,584
+333,664
| +52% | +$1.4M | 0.17% | 111 |
|
|
2022
Q4 | $3.83M | Buy |
636,920
+372,507
| +141% | +$2.24M | 0.19% | 91 |
|
|
2022
Q3 | $1.54M | Sell |
264,413
-103,165
| -28% | -$600K | 0.07% | 157 |
|
|
2022
Q2 | $2.19M | Buy |
367,578
+296,235
| +415% | +$1.77M | 0.11% | 133 |
|
|
2022
Q1 | $333K | Buy |
+71,343
| New | +$333K | 0.02% | 219 |
|